Gialluisi, A.* ; Andlauer, T.F.M.* ; Mirza-Schreiber, N. ; Moll, K.* ; Becker, J.* ; Hoffmann, P.* ; Ludwig, K.U.* ; Czamara, D.* ; Pourcain, B.S.* ; Honbolygó, F.* ; Tóth, D.* ; Csépe, V.* ; Huguet, G.* ; Chaix, Y.* ; Iannuzzi, S.* ; Demonet, J.F.* ; Morris, A.P.* ; Hulslander, J.* ; Willcutt, E.G.* ; DeFries, J.C.* ; Olson, R.K.* ; Smith, S.D.* ; Pennington, B.F.* ; Vaessen, A.* ; Maurer, U.* ; Lyytinen, H.* ; Peyrard-Janvid, M.* ; Leppänen, P.H.T.* ; Brandeis, D.* ; Bonte, M.* ; Stein, J.F.* ; Talcott, J.B.* ; Fauchereau, F.* ; Wilcke, A.* ; Kirsten, H.* ; Müller, B.* ; Francks, C.* ; Bourgeron, T.* ; Monaco, A.P.* ; Ramus, F.* ; Landerl, K.* ; Kere, J.* ; Scerri, T.S.* ; Paracchini, S.* ; Fisher, S.E.* ; Schumacher, J.* ; Nöthen, M.M.* ; Müller-Myhsok, B.* ; Schulte-Körne, G.*
Genome-wide association study reveals new insights into the heritability and genetic correlates of developmental dyslexia.
Mol. Psychiatry 26, 3004–3017 (2021)
Developmental dyslexia (DD) is a learning disorder affecting the ability to read, with a heritability of 40-60%. A notable part of this heritability remains unexplained, and large genetic studies are warranted to identify new susceptibility genes and clarify the genetic bases of dyslexia. We carried out a genome-wide association study (GWAS) on 2274 dyslexia cases and 6272 controls, testing associations at the single variant, gene, and pathway level, and estimating heritability using single-nucleotide polymorphism (SNP) data. We also calculated polygenic scores (PGSs) based on large-scale GWAS data for different neuropsychiatric disorders and cortical brain measures, educational attainment, and fluid intelligence, testing them for association with dyslexia status in our sample. We observed statistically significant (p < 2.8 x 10(-6)) enrichment of associations at the gene level, forLOC388780(20p13; uncharacterized gene), and forVEPH1(3q25), a gene implicated in brain development. We estimated an SNP-based heritability of 20-25% for DD, and observed significant associations of dyslexia risk with PGSs for attention deficit hyperactivity disorder (atp(T) = 0.05 in the training GWAS: OR = 1.23[1.16; 1.30] per standard deviation increase;p = 8 x 10(-13)), bipolar disorder (1.53[1.44; 1.63];p = 1 x 10(-43)), schizophrenia (1.36[1.28; 1.45];p = 4 x 10(-22)), psychiatric cross-disorder susceptibility (1.23[1.16; 1.30];p = 3 x 10(-12)), cortical thickness of the transverse temporal gyrus (0.90[0.86; 0.96];p = 5 x 10(-4)), educational attainment (0.86[0.82; 0.91];p = 2 x 10(-7)), and intelligence (0.72[0.68; 0.76];p = 9 x 10(-29)). This study suggests an important contribution of common genetic variants to dyslexia risk, and novel genomic overlaps with psychiatric conditions like bipolar disorder, schizophrenia, and cross-disorder susceptibility. Moreover, it revealed the presence of shared genetic foundations with a neural correlate previously implicated in dyslexia by neuroimaging evidence.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Reading-disability; Individual-differences; Susceptibility Gene; Molecular-genetics; Language; Comorbidity; Locus; Age; Schizophrenia; Intelligence
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
2020
HGF-reported in Year
2020
ISSN (print) / ISBN
1359-4184
e-ISSN
1476-5578
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 26,
Issue: ,
Pages: 3004–3017
Article Number: ,
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
Campus, 4 Crinan St, London, N1 9xw, England
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30205 - Bioengineering and Digital Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-503200-001
Grants
Projekt DEAL
Fondazione Umberto Veronesi
Max Planck Society
Fraunhofer Society
Max Planck Society within the "Pakt fur Forschung und Innovation"
LIFE-Leipzig Research Center for Civilization Diseases - European Union
European Regional Development Fund (ERDF)
Free State of Saxony within the excellence initiative
Agence Nationale de la Recherche
European Commission
B.M.B.F. through the DIFUTURE consortium of the Medical Informatics Initiative Germany
European Union's Horizon 2020 Research and Innovation Programme (grant MultipleMS)
Wellcome Trust
Munich Cluster for Systems Neurology (SyNergy)
Copyright
Erfassungsdatum
2020-11-05